NCT06239220 2026-02-27PD-L1 t-haNK, NAI IL-15sa and Cetuximab for Recurrent, Metastatic HNSCCDana-Farber Cancer InstitutePhase 2 Recruiting25 enrolled
NCT01385423 2025-07-24Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML)Masonic Cancer Center, University of MinnesotaPhase 1 Completed26 enrolled